Kytopen and BlueWhale Bio partner for cell therapy innovation
The partnership aims to create a non-viral system to expedite engineered cell therapy delivery by addressing bottlenecks.
Cytiva Pipe dream to pipeline WP 3
MD Anderson and Phoenix to advance cell and gene therapy tech
FDA grants RMAT designation to Hope Biosciences’ MS treatment
ExCellThera gains EC authorisation for Zemcelpro cell therapy
Andelyn and Amplo link on AAV gene therapy for NMJ conditions
Apertura signs multiple licensing agreements for TfR1 CapX tech
Japan MHLW approves Biostar’s angel stem cell therapy for autism
Prasad’s FDA exit may accelerate cell and gene therapy approvals
